Connect with us

The Online Technology

Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grail – The Wall Street Journal


News & Analysis

Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grail – The Wall Street Journal

Illumina Inc., a leading maker of the machines that sequence genes, said Monday it will pay $7.1 billion in cash and stock for a developer of a long-sought blood test that promises to detect cancer early. The deal for the part of Grail Inc. that Illumina doesn’t already own will move the company deeper into…

Illumina Inc., a leading maker of the machines that sequence genes, said Monday it will pay $7.1 billion in cash and stock for a developer of a long-sought blood test that promises to detect cancer early.

The deal for the part of Grail Inc. that Illumina doesn’t already own will move the company deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients, a potential multibillion-dollar market.

Real Life. Real News. Real Voices

Help us tell more of the stories that matter

Become a founding member

Illumina…

Subscribe to the newsletter news

We hate SPAM and promise to keep your email address safe

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

To Top